Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Twelve volunteers, in two groups of six, received daptomycin at a dose of 1 or 2 mg/kg. In addition, they received in a randomly allocated order amikacin (500 mg), daptomycin-amikacin, and vancomycin (500 mg). Thirty-five clinical isolates, including Staphylococcus aureus, S. epidermidis, Corynebact...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1989
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2556079/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.10.1783 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|